In summary, although very limited study has been conducted on the expression levels of KLK11 and CLEC3A mRNAs in the SLN tissue in breast cancer, we observed the overexpression of these genes in the positive SLN tissue similar to the CK19 biomarker. The gene discussed is KRT19; the disease is breast carcinoma.